Published in Int J Cancer on August 07, 1996
Cathepsin D--many functions of one aspartic protease. Crit Rev Oncol Hematol (2008) 2.26
Proteolytic networks in cancer. Trends Cell Biol (2011) 2.10
Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation. Mol Genet Metab (2011) 1.27
Proteolytic-antiproteolytic balance and its regulation in carcinogenesis. World J Gastroenterol (2005) 1.20
Protective effects of positive lysosomal modulation in Alzheimer's disease transgenic mouse models. PLoS One (2011) 1.17
Regulation of cancer metastasis by stress pathways. Clin Exp Metastasis (2003) 1.07
Cathepsin B: multiple roles in cancer. Proteomics Clin Appl (2014) 1.03
Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications. Clin Exp Metastasis (2004) 1.00
Cysteine cathepsins are essential in lysosomal degradation of α-synuclein. Proc Natl Acad Sci U S A (2015) 0.87
Alterations in proteolytic activity at low pH and its association with invasion: a theoretical model. Clin Exp Metastasis (1999) 0.85
Knockdown of cathepsin D in zebrafish fertilized eggs determines congenital myopathy. Biosci Rep (2013) 0.85
Evaluation of serum cathepsin B and D in relation to clinicopathological staging of colorectal cancer. World J Gastroenterol (2005) 0.83
Pathogenesis of mitral valve disease in mucopolysaccharidosis VII dogs. Mol Genet Metab (2013) 0.77
The Expression of Lysosomal Proteinases and Their Inhibitors in Breast Cancer: Possible Relationship to Prognosis of the Disease. Pathol Oncol Res (1997) 0.77
High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and Adenocarcinoma. Ann Surg Oncol (2014) 0.76
Immunoradiometric and immunohistochemical analysis of Cathepsin D in ovarian cancer: lack of association with clinical outcome. Br J Cancer (1998) 0.76
The Anti-Cancer Effect of Polyphenols against Breast Cancer and Cancer Stem Cells: Molecular Mechanisms. Nutrients (2016) 0.75
p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res (1990) 5.70
Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet (1992) 3.30
The APC gene product in normal and tumor cells. Proc Natl Acad Sci U S A (1993) 3.25
Problems in assessing contents of metered dose inhalers. BMJ (1993) 3.07
Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res (1979) 2.61
Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin Cancer Res (1997) 2.33
Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene (2008) 2.26
VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. Br J Cancer (2008) 2.09
The isolation and characterization of colorectal epithelial cell lines at different stages in malignant transformation from familial polyposis coli patients. Int J Cancer (1984) 2.04
Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Oncogene (1999) 2.00
Butyrate acts as a survival factor for colonic epithelial cells: further fuel for the in vivo versus in vitro debate. Gastroenterology (1997) 1.99
Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer (1993) 1.94
Interaction of the metalloprotease disintegrins MDC9 and MDC15 with two SH3 domain-containing proteins, endophilin I and SH3PX1. J Biol Chem (1999) 1.85
Starch-Ampicillin Agar for the Quantitative Detection of Aeromonas hydrophila. Appl Environ Microbiol (1985) 1.72
Minimum standards for the management of cleft lip and palate: efforts to close the audit loop. Royal College of Surgeons of England. Ann R Coll Surg Engl (1996) 1.72
An acidic environment leads to p53 dependent induction of apoptosis in human adenoma and carcinoma cell lines: implications for clonal selection during colorectal carcinogenesis. Oncogene (1999) 1.64
Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol Cell Biol (1992) 1.62
CFS hydroxylase cofactor levels in some neurological diseases. J Neurol Neurosurg Psychiatry (1980) 1.59
Neoplastic transformation of a human colonic epithelial cell line: in vitro evidence for the adenoma to carcinoma sequence. Cancer Res (1990) 1.57
Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer (1995) 1.54
Raised cerebrospinal-fluid copper concentration in Parkinson's disease. Lancet (1987) 1.48
Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease. Neurosci Lett (1990) 1.47
Solubility parameters as predictors of miscibility in solid dispersions. J Pharm Sci (1999) 1.45
Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res (2000) 1.44
Influence of surgeon's experience on speech outcome in cleft lip and palate. Lancet (1999) 1.44
Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci (2008) 1.43
Migraine after bone-marrow transplantation. Lancet (1989) 1.43
Updated guidelines for the management of Parkinson's disease. Hosp Med (2001) 1.41
Structural periodicity in human articular cartilage: comparison between magnetic resonance imaging and histological findings. Osteoarthritis Cartilage (1999) 1.41
Colorectal cancer and dietary calcium intervention: a word of caution. Eur J Cancer Prev (1992) 1.39
Index to ring finger length ratio and the risk of osteoarthritis. Arthritis Rheum (2008) 1.36
The incidence of impacted teeth. A survey at Harlem hospital. Oral Surg Oral Med Oral Pathol (1970) 1.35
A study of ras gene mutations in colonic adenomas from familial polyposis coli patients. Oncogene (1988) 1.35
BCL-2 expression in human colorectal adenomas and carcinomas. Oncogene (1994) 1.34
Submandibular duct sialolith of unusual size and shape. J Oral Surg (1975) 1.31
Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev (2003) 1.30
Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent. J Clin Invest (1996) 1.29
Diurnal variation in the femoral articular cartilage of the knee in young adult humans. Magn Reson Med (2000) 1.28
A study to determine the reasons for differences in the tumorigenicity of rat cell lines transformed by adenovirus 2 and adenovirus 12. Cold Spring Harb Symp Quant Biol (1980) 1.27
The catalytic activity of the Src family kinases is required to disrupt cadherin-dependent cell-cell contacts. Mol Biol Cell (2000) 1.26
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology (1999) 1.25
Sexual difficulties of chronic pain patients. Clin J Pain (2001) 1.25
Long-term treatment of parkinsonism with bromocriptine. Lancet (1978) 1.24
A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer. Oncogene (1997) 1.23
Cleft lip and palate care in the United Kingdom--the Clinical Standards Advisory Group (CSAG) Study. Part 3: speech outcomes. Cleft Palate Craniofac J (2001) 1.21
Insulin-like growth factor binding protein 3 (IGFBP-3) potentiates TRAIL-induced apoptosis of human colorectal carcinoma cells through inhibition of NF-kappaB. Cell Death Differ (2006) 1.19
Systematic review of outpatient services for chronic pain control. Health Technol Assess (1997) 1.19
Lifetime body mass index, other anthropometric measures of obesity and risk of knee or hip osteoarthritis in the GOAL case-control study. Osteoarthritis Cartilage (2010) 1.18
No loss of cartilage volume over three years in patients with knee osteoarthritis as assessed by magnetic resonance imaging. Osteoarthritis Cartilage (2002) 1.17
Encephalopathy associated with ifosphamide/mesna therapy. Lancet (1985) 1.17
Xenobiotic metabolism in motor neuron disease. Lancet (1988) 1.16
Xenobiotic metabolism in Parkinson's disease. Neurology (1989) 1.16
Tumorigenicity and in vitro characteristics of rat liver epithelial cells and their adenovirus-transformed derivatives. Int J Cancer (1980) 1.15
Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm (2000) 1.15
Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro. J Biol Chem (1998) 1.14
Cleft lip and palate care in the United Kingdom--the Clinical Standards Advisory Group (CSAG) Study. Part 4: outcome comparisons, training, and conclusions. Cleft Palate Craniofac J (2001) 1.12
Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells. Cancer Res (2000) 1.12
Coordinated modulation of the fibroblast growth factor dual receptor mechanism during transformation from human colon adenoma to carcinoma. Int J Cancer (1999) 1.10
Acute angle-closure glaucoma following botulinum toxin injection for blepharospasm. Br J Ophthalmol (1990) 1.10
O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. Eur J Biochem (1994) 1.09
The development of a battery of measures for assessing physical functioning of chronic pain patients. Pain (1994) 1.08
Effects of a metalloproteinase inhibitor on osteochondral angiogenesis, chondropathy and pain behavior in a rat model of osteoarthritis. Osteoarthritis Cartilage (2010) 1.08
Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398. Int J Cancer (2000) 1.08
Butyrate can act as a stimulator of growth or inducer of apoptosis in human colonic epithelial cell lines depending on the presence of alternative energy sources. Carcinogenesis (1997) 1.07
Radiographic assessment of the index to ring finger ratio (2D:4D) in adults. J Anat (2007) 1.07
Mutations in the interglobular domain of aggrecan alter matrix metalloproteinase and aggrecanase cleavage patterns. Evidence that matrix metalloproteinase cleavage interferes with aggrecanase activity. J Biol Chem (2000) 1.07
Attempt to replicate published genetic associations in a large, well-defined osteoarthritis case-control population (the GOAL study). Osteoarthritis Cartilage (2008) 1.06
Spinal cord stimulation and the relief of chronic pain. J Neurol Neurosurg Psychiatry (1987) 1.06
Immunodetection of cathepsins B and L present in and secreted from human pre-malignant and malignant colorectal tumour cell lines. Int J Cancer (1989) 1.06
A meta-analysis of interleukin-6 promoter polymorphisms on risk of hip and knee osteoarthritis. Osteoarthritis Cartilage (2010) 1.05
Cleft lip and palate care in the United Kingdom--the Clinical Standards Advisory Group (CSAG) Study. Part 1: background and methodology. Cleft Palate Craniofac J (2001) 1.03
TGF-beta expression in the human colon: differential immunostaining along crypt epithelium. Br J Cancer (1993) 1.02
The role of butyrate in human colonic epithelial cells: an energy source or inducer of differentiation and apoptosis? Proc Nutr Soc (1996) 1.02
Extrapyramidal reactions to anti-inflammatory drugs. J Neurol Neurosurg Psychiatry (1988) 1.02
Characterisation of the guinea pig model of osteoarthritis by in vivo three-dimensional magnetic resonance imaging. Osteoarthritis Cartilage (2003) 1.02
Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies. J Pharm Pharmacol (1999) 1.01
Differential growth response to oestrogen of premalignant and malignant colonic cell lines. Anticancer Res (1994) 1.01
Experiences with local chemotherapy and immunotherapy in premalignant and malignant skin lesions. Cancer (1970) 1.01
Smoking habits of Florida physicians revisited. JFMA (1972) 1.01
Hydroxylase cofactor activity in cerebrospinal fluid of normal subjects and patients with Parkinson's disease. Science (1979) 1.01
The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2. Gut (2005) 1.00
Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways. Oncogene (2012) 1.00
Stridor during dystonic phases of Parkinson's disease. J Neurol Neurosurg Psychiatry (1987) 1.00
Patients' and professionals' understandings of the causes of chronic pain: blame, responsibility and identity protection. Soc Sci Med (1997) 0.99
Motoneurone disease as manifestation of pesticide toxicity. Lancet (1987) 0.99
Idiopathic dysautonomia treated with intravenous gammaglobulin. Lancet (1996) 0.98
Expression of CDX2 in normal and neoplastic human colon tissue and during differentiation of an in vitro model system. Gut (2002) 0.98
Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro. J Pharm Pharmacol (2001) 0.98
Derepression of synthesis of the aminoacyl-transfer ribonucleic acid synthetases for the branched-chain amino acids of Escherichia coli. J Bacteriol (1974) 0.98
Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine. Immunology (1990) 0.98
Can cartilage loss be detected in knee osteoarthritis (OA) patients with 3-6 months' observation using advanced image analysis of 3T MRI? Osteoarthritis Cartilage (2010) 0.98
COX-2 inhibitors for colorectal cancer. Nat Med (1998) 0.97
Loss of APC protein expressed by human colonic epithelial cells and the appearance of a specific low-molecular-weight form is associated with apoptosis in vitro. Int J Cancer (1994) 0.97
Bax inhibitor 1 in apoptosis and disease. Oncogene (2011) 0.97
bcl-2 and bak may play a pivotal role in sodium butyrate-induced apoptosis in colonic epithelial cells; however overexpression of bcl-2 does not protect against bak-mediated apoptosis. Int J Cancer (1997) 0.96